Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Laser Speckle Imaging System (RFLSI CZW)

K-Number: K233076 · 2024-05-28

Decision Date2024-05-28
Product CodeDPT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Laser Speckle Imaging System (RFLSI CZW) is a medical device manufactured by Rwd Life Science Co., Ltd.. It received FDA 510(k) clearance on 2024-05-28 under approval number K233076. The device is classified under product code DPT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Laser Speckle Imaging System (RFLSI CZW)?

Laser Speckle Imaging System (RFLSI CZW) is a medical device that received FDA 510(k) clearance on 2024-05-28. It is manufactured by Rwd Life Science Co., Ltd.. The 510(k) number is K233076.

When was Laser Speckle Imaging System (RFLSI CZW) approved by the FDA?

Laser Speckle Imaging System (RFLSI CZW) received FDA 510(k) clearance on 2024-05-28, under approval number K233076.

What company makes Laser Speckle Imaging System (RFLSI CZW)?

Laser Speckle Imaging System (RFLSI CZW) is manufactured by Rwd Life Science Co., Ltd..

What is the FDA product code for Laser Speckle Imaging System (RFLSI CZW)?

The FDA product code for Laser Speckle Imaging System (RFLSI CZW) is DPT.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DPT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.